Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000520242 | SCV000618790 | likely pathogenic | not provided | 2017-07-05 | criteria provided, single submitter | clinical testing | The R1352L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R1352L variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R1352L variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R1349Q, V1350L, P1353L) have been reported in the Human Gene Mutation Database in association with CACNA1A-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |
Undiagnosed Diseases Network, |
RCV003985376 | SCV000746594 | likely pathogenic | CACNA1A-related disorder | 2017-08-29 | criteria provided, single submitter | clinical testing |